The Nasdaq Composite, S&P 500, and Dow Jones Industrial Average are hovering near their all-time highs in December. The U.S. stock market kick-started a rally after Trump’s election victory in early November. Investors are taking entry positions in top U.S. stocks before Trump’s inauguration, hoping the economy will boom under his watch.

Also Read: Tesla Eyes 6th Straight Day of Gains: So Why Is Goldman Sachs ‘Cautious’?

Trump’s election triumph has also benefitted the cryptocurrency market as Bitcoin climbed above the $100,000 milestone this month. This article will highlight the top U.S. stocks to buy before Trump takes office on January 20, 2025. His policies could benefit these stocks as they play a direct role in Americans’ economy and consumer habits.

2 U.S. Stocks To Watch Out For Before Trump Takes Office

1. Mastercard (NYSE: MA)

mastercard
Source: BBC

The multinational payment services Mastercard is the top pick among the U.S. stocks before Trump’s inauguration. The growing economy could make American consumerism grow, leading to bigger swipes on cards. Mastercard stock is the “top pick for a world that never stops buying,” said David Materazzi, CEO of automated trading platform Galileo FX, who expects this will happen if the economy picks up steam.

Also Read: META Stock Hits All-Time High as Ad Revenue Passes $100B

“If the economy gets a boost, Mastercard becomes a direct beneficiary. Every transaction fuels its growth. With digital payments growing and cash fading fast, Mastercard isn’t just riding the wave; it is the wave,” said Materazzi to GOBankingRates, explaining why it is among the top U.S. stock picks.

2. Bio-Rad Laboratories (NYSE: BIO)

Bio Rad Laboratories
Source: teamwrkx.com

The top U.S. stocks to buy are aplenty, but the best among them to watch out for is Bio-Rad Laboratories. Following Trump’s victory, it received a ‘buy call’ from Dave Sekera, Chief US Market Strategist at Morningstar. He wrote that Bio-Rad Laboratories is undervalued and is primed to rebound in a few months. “We think it relies on that razor and razor blade business model,” Sekera said in a recent analysis.

Also Read: Alphabet’s (GOOGL) Waymo Expands: Why Its Huge for the Stock in 2025

“Consumable reagents account for 70% of their total sales. And of course, those reagents are often sold at a higher margin than what we see for the equipment and the instruments,” he said.